Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
MediPal Holdings (TSE:7459) has drawn fresh attention after recent share performance data highlighted a 1 day decline of 3.8% alongside gains over the past week, month, past 3 months, year, and longer periods. For context, MediPal Holdings now trades at ¥2,950, with the 1 day share price return down 3.85%, the 3 month share price return up 12.57%, and the 1 year total shareholder return at 18.81%, suggesting momentum has been building rather than fading. Compare MediPal Holdings' recent...
Since April 2026, Silchester has had a number of discussions with the Company. Silchester has come to hold serious concerns about the Company's fundamental attitude toward its shareholders. Accordingly, on 2 September 2026, Silchester formally demanded, pursuant to Article 297, Paragraph 1 of the Companies Act, that the Company convene an extraordinary general meeting of shareholders (the "EGM") to consider the four proposals summarised below. Silchester has asked that the EGM be held no later t
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.